Quick Answer
Inspire Medical Systems, Inc. reported Research And Development Expense of $103.17 million for the year ending 2025.
- Inspire Medical Systems, Inc. showed a decrease of -9.6% in Research And Development Expense from 2024 to 2025.
- This data is from Inspire Medical Systems, Inc.'s annual report (Form 10-K), filed with the SEC on February 13, 2026.
- XBRL data for this metric is available from 2016 to 2025 (10 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q1 2017: $1.59 million | Q2 2017: $1.74 million | Q3 2017: $1.18 million | Q1 2018: $1.73 million | Q2 2018: $1.74 million | Q3 2018: $1.77 million | Q1 2019: $2.60 million | Q2 2019: $2.85 million | Q3 2019: $3.62 million | Q1 2020: $5.44 million | Q2 2020: $6.06 million | Q3 2020: $7.31 million | Q1 2021: $8.15 million | Q2 2021: $9.29 million | Q3 2021: $9.61 million | Q1 2022: $11.87 million | Q2 2022: $14.53 million | Q3 2022: $20.99 million | Q1 2023: $25.52 million | Q2 2023: $30.82 million | Q3 2023: $29.14 million | Q1 2024: $28.85 million | Q2 2024: $28.86 million | Q3 2024: $26.08 million | Q1 2025: $27.80 million | Q2 2025: $26.21 million | Q3 2025: $24.21 million.
- Over the full 10 years of available data (2016 to 2025), Inspire Medical Systems, Inc.'s Research And Development Expense has grown by 1,354.9%.
- Historical annual values: Fiscal year 2025: $103.17 million | Fiscal year 2024: $114.13 million | Fiscal year 2023: $116.54 million | Fiscal year 2022: $68.65 million | Fiscal year 2021: $37.35 million | Fiscal year 2020: $26.09 million | Fiscal year 2019: $12.84 million | Fiscal year 2018: $7.39 million | Fiscal year 2017: $6.19 million | Fiscal year 2016: $7.09 million.
- Data sourced from SEC EDGAR public filings as of August 7, 2026.
Last verified: